CSF2 and neoplasm: Therefore, a sustained local release strategy such as GM-CSF-secreting tumor vaccine or through engineering of GM-CSF-producing immune cells may help to reduce the immunosuppressive effects while exploiting the immunostimulatory functions of GM-CSF.